Syringe Aldehyde Extraction via Thermal Treatment and Derivatization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for reducing aldehyde release from syringe adhesives are non-specific and unstable, and current detection methods are not precise enough to handle low concentrations, especially when syringes contain protein-based medicaments, leading to contamination issues.
Innovation Solution
A method involving treating syringes at temperatures higher than 50°C, preferably 90°C, combined with a derivatization treatment using a compound like 2,4-dinitrophenyl hydrazine followed by reverse phase HPLC coupled to a UV detector for precise aldehyde detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-generated harmful factors
If autoclave treatment is used to reduce aldehyde release, then aldehyde levels decrease, but the gluing seal weakens and rubber components are damaged
Solution Approach 1:
The patent applies parameter changes by modifying the temperature and time parameters of the thermal treatment process. Instead of using standard autoclave conditions (121°C for 15-30 minutes), the patent uses lower temperature (50-90°C) combined with extended time (1-24 hours) to achieve aldehyde reduction while preserving adhesive bond strength and rubber component integrity.
2Difficulty of detecting and measuring
If liquid chromatography is used for aldehyde detection, then detection capability is provided, but precision and sensitivity are insufficient for low concentrations
Solution Approach 1:
The patent applies the intermediary principle by introducing a derivatization agent (2,4-dinitrophenylhydrazine) that reacts with aldehydes to form hydrazones. This intermediary chemical reaction transforms the aldehydes into compounds with enhanced UV-Vis detectability, enabling precise measurement at low concentrations (ng/mL range) that were previously undetectable.
Solution Approach 2:
The patent utilizes color changes through the derivatization reaction where aldehydes react with 2,4-dinitrophenylhydrazine to form colored hydrazone products. These products exhibit strong UV-Vis absorption characteristics, allowing sensitive detection and quantification of trace aldehyde levels through chromatic properties.
3Measurement precision
If PFBHA derivatization is used, then some aldehydes can be detected, but the method is not stable and cannot detect all aldehydes simultaneously at ng/mL levels
Solution Approach 1:
The patent improves reliability by optimizing multiple reaction parameters including pH (adjusted to acidic conditions), temperature (heating to 40-55°C), reaction time (1.5-2.5 hours), and solvent composition (water/acetonitrile mixture). These parameter optimizations ensure consistent and stable derivatization reactions for all target aldehydes, eliminating the variability observed with PFBHA.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively reduces aldehyde release to low levels (<60 ng/syringe for formaldehyde, <300 ng/syringe for acetaldehyde, and <20 ng/syringe for acrolein) and provides a highly sensitive and specific analytical method for detecting residual aldehydes, ensuring syringes are safe for use with protein-containing fluids.
Implementation Method 1
aldehydes are not detectable per se at low concentrations (ng/mL) if they are not first bound to a substance which allows the discrimination thereof, forming a chromophore product (hydrazone) therewith
Implementation Method 2
reverse phase HPLC coupled to UV detector
Implementation Method 3
coupled to UV detector
Data Source
Figure 1~2A
Figure 2B~2C
AI summary
The present invention relates to a method for extracting aldehydes from the adhesive used for gluing needles to syringes, and to a method for determining the aldehydes releasable from said syringes, before or after such a treatment. In particular, the present invention relates to a method for extracting residual aldehydes from syringes comprising a step of treating said syringes at a temperature higher than or equal to 50°C, preferably higher than or equal to 90°C, wherein said treatment step is preferably carried out in an autoclave at a temperature higher than 90°C and at a pressure higher than atmospheric pressure.